# ALUNBRIG
> **NDA208772** · New Drug Application · Sponsor: TAKEDA PHARMS USA · Approved 2017-04-28
## Drug
- **FDA Application Number:** NDA208772
- **Application type:** New Drug Application
- **Brand name:** ALUNBRIG
- **Generic name:** BRIGATINIB
- **Active ingredients:** BRIGATINIB
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TAKEDA PHARMS USA
- **Manufacturer:** Takeda Pharmaceuticals America, Inc.
- **First approval:** 2017-04-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208772)
---
*MORVS · CC0 1.0*